Kindred Healthcare, Inc. (NYSE:KND) had its target price reduced by equities researchers at Deutsche Bank AG from $13.00 to $10.00 in a research report issued to clients and investors on Monday. The brokerage currently has a “buy” rating on the health services provider’s stock. Deutsche Bank AG’s target price indicates a potential upside of 21.95% from the stock’s previous close.

Several other equities research analysts also recently commented on the company. BidaskClub downgraded Kindred Healthcare from a “hold” rating to a “sell” rating in a report on Monday, July 31st. Zacks Investment Research downgraded Kindred Healthcare from a “hold” rating to a “sell” rating in a report on Thursday, July 6th. Mizuho reaffirmed a “neutral” rating and set a $9.00 target price on shares of Kindred Healthcare in a report on Monday, July 3rd. Royal Bank Of Canada reaffirmed a “hold” rating and set a $10.00 target price on shares of Kindred Healthcare in a report on Monday, May 15th. Finally, Barclays PLC reaffirmed a “buy” rating and set a $13.00 target price (up from $11.00) on shares of Kindred Healthcare in a report on Sunday, May 7th. Five equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $9.94.

Kindred Healthcare (KND) traded down 4.573% during mid-day trading on Monday, reaching $7.825. The company had a trading volume of 1,372,266 shares. The firm’s market capitalization is $670.08 million. The stock’s 50-day moving average is $10.88 and its 200 day moving average is $9.21. Kindred Healthcare has a 12 month low of $5.65 and a 12 month high of $12.32.

Kindred Healthcare (NYSE:KND) last announced its earnings results on Thursday, August 3rd. The health services provider reported $0.19 EPS for the quarter, beating the consensus estimate of $0.16 by $0.03. Kindred Healthcare had a positive return on equity of 3.49% and a negative net margin of 16.31%. The business had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the prior year, the business posted $0.38 earnings per share. Kindred Healthcare’s revenue was down 4.6% compared to the same quarter last year. On average, analysts predict that Kindred Healthcare will post $0.50 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This story was first reported by American Banking News and is the property of of American Banking News. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. & international trademark and copyright laws. The original version of this story can be viewed at https://www.americanbankingnews.com/2017/08/07/kindred-healthcare-inc-nyseknd-given-new-10-00-price-target-at-deutsche-bank-ag.html.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Phoenix Investment Adviser LLC raised its position in Kindred Healthcare by 20.9% in the second quarter. Phoenix Investment Adviser LLC now owns 179,000 shares of the health services provider’s stock valued at $2,085,000 after buying an additional 31,000 shares during the last quarter. State Board of Administration of Florida Retirement System raised its position in Kindred Healthcare by 103.5% in the second quarter. State Board of Administration of Florida Retirement System now owns 122,906 shares of the health services provider’s stock valued at $1,432,000 after buying an additional 62,509 shares during the last quarter. BNP Paribas Arbitrage SA raised its position in Kindred Healthcare by 37.6% in the second quarter. BNP Paribas Arbitrage SA now owns 37,574 shares of the health services provider’s stock valued at $438,000 after buying an additional 10,268 shares during the last quarter. Gamco Investors INC. ET AL raised its position in Kindred Healthcare by 57.0% in the second quarter. Gamco Investors INC. ET AL now owns 431,746 shares of the health services provider’s stock valued at $5,030,000 after buying an additional 156,700 shares during the last quarter. Finally, GABELLI & Co INVESTMENT ADVISERS INC. acquired a new position in Kindred Healthcare during the second quarter valued at $512,000. 88.88% of the stock is currently owned by hedge funds and other institutional investors.

Kindred Healthcare Company Profile

Kindred Healthcare, Inc is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Analyst Recommendations for Kindred Healthcare (NYSE:KND)

Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.